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Abstract
 
To study the adaptation of natural killer (NK) cells to their major histocompatibility complex
(MHC) class I environment we have established a novel mouse model with mosaic expression
 
of H-2D
 
d
 
 using a Cre/loxP system. In these mice, we noticed that NK cells expressing the in-
hibitory receptor for D
 
d
 
, Ly49A, were specifically underrepresented among cells with low D
 
d
 
levels. That was due to the acquisition of D
 
d
 
 molecules by the Ly49A
 
 
 
 NK cells that have lost
their D
 
d
 
 transgene. The uptake of H-2D molecules via the Ly49A receptor was restricted to
strong ligands of Ly49A. Surprisingly, when Ly49A
 
 
 
 NK cells were D
 
d
 
 
 
, uptake of the alterna-
tive ligand D
 
k
 
 was not detectable. Similarly, one anti-Ly49A mAb (A1) bound inefficiently
when Ly49A was expressed on D
 
d
 
 
 
 NK cells. Concomitantly, functional assays demonstrated a
reduced capacity of Ly49A to inhibit H-2
 
b
 
D
 
d
 
 as compared with H-2
 
b
 
 NK cells, rendering
Ly49A
 
 
 
 NK cells in D
 
d
 
 
 
 mice particularly reactive. Minor reductions of D
 
d
 
 levels and/or in-
creases of activating ligands on environmental cells may thus suffice to abrogate Ly49A-medi-
ated NK cell inhibition. The mechanistic explanation for all these phenomena is likely the par-
tial masking of Ly49A by D
 
d
 
 on the same cell via a lateral binding site in the H-2D
 
d
 
 molecule.
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Introduction
 
NK cells are lymphocytes capable of killing various tumor
and virally infected target cells and produce cytokines (in
 
particular IFN-
 
 
 
) and chemokines (1). An inverse correla-
tion exists between the expression levels of MHC class I
molecules on potential target cells and their susceptibility to
NK cell–mediated lysis, a pattern termed missing self-rec-
ognition (2). Normal levels of MHC class I molecules ex-
pressed by normal cells prevent lysis by autologous NK
cells. Reduced expression or loss of MHC class I molecules
and/or increased expression of ligands for activating NK
cell receptors, which can occur upon malignant transfor-
mation or viral infection, will abrogate NK cell inhibition
and lead to target cell lysis (3–5).
NK cells express inhibitory receptors that preclude NK
cell reactivity upon recognition of MHC class I molecules
on target cells. In the mouse, inhibitory receptors specific
for MHC class Ia molecules belong to the Ly49 receptor
family (for review, see references 6 and 7). Some of these
C-type lectin-like receptors are able to discriminate poly-
morphic MHC class Ia molecules. For example, the inhibi-
tory Ly49A receptor interacts strongly with class I mole-
cules such as H-2D
 
d
 
 (D
 
d
 
) and D
 
k
 
, but only very weakly
with D
 
b
 
 (8–10). The selectivity of some Ly49 receptors to-
gether with their combinatorial distribution allows NK
cells to react to subtle changes in a cell’s MHC make up,
such as the absence of a single class I allele (11).
The MHC class I environment in which NK cells arise
influences their reactivity to target cells. NK cells do not
reject syngeneic bone marrow grafts, e.g., H-2
 
b
 
 mice ac-
cept H-2
 
b
 
 grafts. However, upon the expression of a D
 
d
 
transgene (Tg)
 
* 
 
in H-2
 
b
 
 mice, NK cells acquire the capac-
ity to reject bone marrow grafts from H-2
 
b
 
 donors, while
they are unreactive to syngeneic H-2
 
b
 
D
 
d
 
 grafts (12, 13).
NK cells adapt to the presence of the Tg D
 
d
 
 molecule, ac-
quiring tolerance toward MHC-identical (D
 
d
 
 
 
) cells and
reactivity to cells that lack D
 
d
 
, a pattern we have termed
missing D
 
d
 
-reactivity. Self-tolerance of H-2
 
b
 
D
 
d
 
 Ly49A
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Conditions for Ly49A-mediated H-2D Ligand Uptake
 
NK cells is indeed ensured via the inhibitory effect of
Ly49A. In contrast, the analysis of H-2
 
b
 
 Ly49A
 
 
 
 NK cells
revealed that self-tolerance was independent of Ly49A
function. (14–16).
The cellular and molecular basis for the NK cells adapta-
tion to their MHC class I environment is still not well un-
derstood. To study these processes we have engineered a
genetic “off-switch” for D
 
d
 
 using an inducible Cre/loxP
system (13). D
 
d
 
 Tg mice were generated using a genomic
D
 
d
 
 clone, which is flanked by loxP sites. The loxP sites can
be recognized by Cre recombinase, leading to the deletion
of the flanked sequence and consequently shutdown of D
 
d
 
expression. These D
 
d
 
 Tg mice were crossed to mice har-
boring a Cre Tg that is under the control of the IFN-
 
 
 
 re-
sponsive Mx promoter (17). Lymphocytes in D
 
d
 
 
 
  
 
MxCre
double Tg mice displayed variable D
 
d
 
 levels even without
deliberate Cre induction (13). In these and other mice with
mosaic expression of a D
 
d
 
 Tg, i.e., where in individual
mice H-2
 
b
 
D
 
d
 
 and H-2
 
b
 
 cells coexist, NK cells failed to ap-
propriately acquire missing-D
 
d
 
 reactivity (13, 18). Missing-D
 
d
 
reactivity in D
 
d
 
 single Tg mice is performed by Ly49A-
expressing NK cells (14). In the D
 
d
 
 mosaic situation these
cells failed to acquire missing-D
 
d
 
 reactivity (13).
To explore the basis for the differential behavior of
Ly49A
 
 
 
 NK cells we have compared the Ly49A
 
 
 
 NK cell
subsets of B6 (H-2
 
b
 
), D
 
d
 
 single (H-2
 
b
 
D
 
d
 
), and D
 
d
 
 
 
  
 
MxCre
double Tg mice. During these analyses we have noticed
that in D
 
d
 
 
 
  
 
MxCre double Tg mice only very few
Ly49A
 
 
 
 NK cells were devoid of D
 
d
 
. We show that this is
due to an ability of the Ly49A NK cell receptor to acquire
D
 
d
 
 molecules from environmental D
 
d
 
-expressing cells. In-
terestingly, however, H-2 ligand expression by Ly49A
 
 
 
NK cells prevented ligand uptake from environmental
cells. Further experiments suggested that the Ly49A recep-
tor in D
 
d
 
 
 
 
 
mice is poorly accessible and concomitantly that
the capacity of Ly49A to signal NK cell inhibition is drasti-
cally reduced. These findings and their implications for NK
cell function are discussed in the context of the recent reso-
lution of the crystallographic structure of the Ly49A/H-2D
 
d
 
complex (19).
 
Materials and Methods
 
Mice.
 
C57BL/6 (B6) (CD45.2, H-2
 
b
 
), B10.D2 (H-2
 
d
 
), and
B10.BR (H-2
 
k
 
) mice were purchased from Harlan OLAC. Con-
genic B6 CD45.1 and 
 
 
 
2-microglobulin (
 
 
 
2m)-deficient B6
mice were purchased from The Jackson Laboratory. Ly49A Tg
mice were described previously (20). Floxed D
 
d
 
 Tg mice, back-
crossed to B6 mice, were described elsewhere (13). Mx1-Cre Tg
mice were provided by M. Aguet, Institut Swisse De Recherche
Experimentale Sur Le Cancer, Epalinges, Switzerland (17). All
mice were older than 6 wk when used for experiments.
Cre expression was induced by intraperitoneal injection of the
IFN-inducer polyinosinic-polycytidylic acid (polyI/C; Sigma-
Aldrich). Mice received 250 
 
 
 
g polyI/C intraperitoneal (diluted
in PBS) on days 0, 2, and 4. Control mice received PBS. The
lymphoid organs were analyzed 10 d after the last injection.
 
Antibodies and Flow Cytometry.
 
Cell suspensions (usually 10
 
6
 
cells per sample) were incubated with 24G2 (anti-CD16/32) hy-
 
bridoma culture supernatant to reduce background. For surface
stainings, the following mAbs were obtained from BD PharMin-
gen unless otherwise indicated: 34–2-12 (anti-H-2D
 
d
 
), 34–4-20S
(anti-H-2D
 
d
 
, obtained from American Type Culture Collec-
tion), 15–5-5 (anti-H-2D
 
k
 
), KH95 (anti-H-2D
 
b
 
), JR9–318
(anti-Ly49A [reference 21], provided by J. Roland, Institut Pas-
teur, Paris, France), A1 (anti-Ly49A
 
B6
 
), YE1–48 (anti-Ly49A
[reference 22], provided by F. Takei, University of British Co-
lumbia, Vancouver, Canada), 5E6 (anti-Ly49C/I), 4D11 (anti-
Ly49G2), 4E5 (anti-Ly49D), 145–2C11 (anti-CD3
 
 
 
), PK136
(anti-NK1.1), RA3–6B2 (anti-CD45R/B220), A20 (anti-
CD45.1), and 104 (anti-CD45.2). These mAbs were used either
biotinylated or conjugated to different fluorochromes (FITC,
PE, Cy-Chrome
 
TM
 
 [Cy], Cy 5, allophycocyanin [APC]) to allow
three or four color flow cytometry. Biotinylated mAbs were re-
vealed through staining with either streptavidin-Cy (BD Phar-
Mingen) or streptavidin-APC (Molecular Probes). The samples
were analyzed on a FACSCalibur™ flow cytometer (Becton
Dickinson) using CELLQuest™ software (Becton Dickinson) for
data evaluation.
 
Mixed Bone Marrow Chimeras.
 
Recipient mice were injected
intraperitoneally with 100 
 
 
 
g of purified PK136 mAb (anti-
NK1.1) to deplete NK cells. They were lethally irradiated 24 h
later (960 rad from a 
 
137
 
Cs source). 1 d after the irradiation, the
recipient mice were reconstituted by intravenous injection of a
1:1 mixture of Thy-1–depleted bone marrow cells from B6 and
H-2
 
b
 
D
 
d
 
 mice (10
 
6
 
 cells from each donor type). Antibiotics were
added to the drinking water during the first 4 wk after reconsti-
tution.
 
In Vitro Uptake of MHC Class I Molecules.
 
Total, erythrocyte-
depleted splenocytes from two mice with different MHC haplo-
types (2 
 
 
 
 10
 
6
 
 cells of either type) were mixed, centrifuged, and
resuspended in 1 ml of culture medium.
After 2 h at 37
 
 
 
C, the cells were washed in culture medium
and then stained for flow cytometry as described previously. For
Ab-blocking studies, the cells were mixed and resuspended
(without the initial centrifugation step) in 1 ml of culture me-
dium, 1 ml of 34–4-20S (anti-D
 
d
 
) hybridoma culture supernatant,
or 10 
 
 
 
g of purified A1 (anti–Ly49A
 
B6
 
) in 1 ml of culture me-
dium. Stainings were performed with mAbs specific for epitopes
that are different from those used for blocking: 34–2-12 for D
 
d
 
and JR9–318 for Ly49A.
 
NK Cell Culture.
 
Nylon wool nonadherent splenocytes were
cultured in complete DMEM supplemented with 10% FCS,
 
L
 
-glutamine, Hepes buffer, 
 
 
 
2-mercaptoethanol, and penicillin/
streptomycin (all from Life Technologies) containing 500 ng/ml
of recombinant human IL-2 (a gift from Glaxo IMB). The cells
were incubated at 37
 
 
 
C at a density of 2 
 
 
 
 10
 
6
 
 cells per milliliter
in a total volume of 10 ml/flask. At day 3, cells were either used
for cytotoxicity assays or adherent cells were restimulated for 7
more days with fresh medium containing IL-2.
 
Chromium Release Assays.
 
To determine cytotoxic activities,
a conventional 
 
51
 
Cr-release assay was performed. Briefly, 10
 
6
C1498 or Dd transfected C1498 cells (provided by W. Seaman,
University of California at San Francisco, San Francisco, CA)
were labeled with 50  Ci of 51Cr for 1 h at 37 C. After three
washes, 5   103 labeled target cells were mixed with effector cells
in duplicate at various E:T ratios in 96-well U-bottomed plates.
After 4 h of incubation at 37 C, supernatants were harvested and
radioactivity was measured in a  -counter. The percentages of
NK cells (NK1.1 CD3 ) in the effector cell cultures were deter-
mined using flow cytometry. The lysis curves were shifted rela-
tive to the content of NK cells in the B6 effector cell population.1533 Zimmer et al.
Results
Heterogeneous Expression of Dd in Dd   MxCre Double Tg
Mice. Lymphocytes in Dd single Tg mice, backcrossed to
B6 mice (i.e., being H-2bDd) homogeneously expressed
high levels of Dd (Fig. 1 a). In contrast, heterogeneous Dd
expression with high, intermediate, and low Dd levels was
observed in lymphocytes from unmanipulated Dd   Mx-
Cre double Tg mice (Fig. 1 a). Expression levels of Dd on
the Dd high lymphocytes were similar to those in Dd single
Tg mice. The Dd intermediate population may represent
cells with a partial recombination of the multicopy Tg lo-
cus. In individual mice, the fraction of Dd low cells was
comparable among NK, T, B, and NK T cells of several
organs (spleen, bone marrow, peripheral blood) (Fig. 1 b
and data not shown). With increasing age of the mice also
the fraction of Dd low cells increased (data not shown).
This “spontaneous” loss of Dd expression, which oc-
curred in the absence of any deliberate promoter induction
through injection of IFN-  or of the IFN-inducer polyI/C
may be the consequence of endogenous IFN production in
mice housed under conventional conditions (i.e., in a non-
sterile environment). Alternatively, it may be due to leaki-
ness of the inducible Cre Tg system.
Ly49A  Cells Are Underrepresented among Dd Low NK
Cells of Dd   MxCre Mice. The partial loss of Dd expres-
sion had no significant effect on the abundance of NK cells
in spleen and in bone marrow (data not shown). Since NK
cells themselves were Dd high, intermediate, and low, we
determined whether Ly49 receptors were equally abundant
in the different populations. No differences were observed
regarding the expression of Ly49C/I (Fig. 2), Ly49G2, or
Ly49D (data not shown). Unexpectedly, Ly49A was ex-
pressed on few (6   3%) Dd low NK cells, contrasting with
a relatively normal percentage of expression on Dd high
NK cells (22   5%; Fig. 2). However, an expanded popu-
lation of Ly49A  cells was detected among NK cells with
intermediate Dd levels (32   7%; Fig. 2). Yet, the fraction
of Ly49A  cells among total NK cells of Dd   MxCre
mice (18   3%) was in the same range as that of nonTg
H-2b (18   3%) or Dd Tg mice (16   2%). These results
Figure 1. Heterogeneous Dd Tg expression in Dd   MxCre double Tg
mice. (a) Histograms show Dd expression on splenocytes from nonTg (H-2b)
(left), Dd single Tg (H-2bDd) (middle), and Dd   MxCre double Tg (right)
mice. Numbers in histograms indicate the percentages of splenocytes with
low, intermediate, and high Dd expression, respectively. (b) Histograms
show Dd expression on splenic NK cells (NK1.1 CD3 ), T cells
(NK1.1 CD3 ), and B cells (CD45R/B220 ) of a representative Dd  
MxCre double Tg mouse. Numbers in histograms indicate the percent-
ages of splenocytes with low, intermediate, and high Dd expression, re-
spectively. A comparable Dd distribution was found in all Dd   MxCre
mice analyzed, even though the percentages of Dd low cells varied and
tended to increase with age.
Figure 2. Reduced presence of Ly49A  NK cells with low Dd levels.
Splenocytes from representative non Tg (H-2b), Dd single Tg (H-2bDd),
and Dd   MxCre double Tg mice were stained with mAbs to Ly49A or
Ly49C/I, NK1.1, CD3, and Dd and analyzed by four color flow cytome-
try. (a) NK cells (NK1.1 CD3 ) were gated among total splenocytes and
analyzed for Ly49A and Ly49C/I expression. Numbers indicate the per-
centages of Ly49A  (top histograms) and Ly49C/I  (bottom histograms)
cells among NK cells from the indicated types of mice. The expression
levels of Ly49A and Ly49C/I are indicated as MFI. (b) Gated NK cells
(NK1.1 CD3 ) from a representative Dd   MxCre double Tg mouse
were subdivided according to Dd expression into Dd low, intermediate,
and high cells. Numbers indicate the percentages of Ly49A  (top histo-
grams) and Ly49C/I  cells (lower histograms) among the different NK
cell subpopulations. The expression levels of Ly49A and Ly49C/I are in-
dicated as MFI. (c) The density plots show expression of Ly49A (left) and
Ly49C/I (right) versus Dd on splenic NK cells (NK1.1 CD3 ) from a
Dd   MxCre mouse.1534 Conditions for Ly49A-mediated H-2D Ligand Uptake
suggest that Ly49A  NK cells are somehow more resistant
to complete Dd loss compared with Ly49A  NK cells.
Ly49A expression levels, measured by the mean fluores-
cence intensity (MFI) of Ly49A staining, were 39   7% on
H-2bDd as compared with H-2b NK cells, as reported pre-
viously (14). In Dd   MxCre mice, Ly49A levels were
comparably reduced (30   7% relative to H-2b mice).
However, the three Dd-defined NK cell subsets expressed
different Ly49A cell surface levels (Fig. 2). Ly49A expres-
sion levels on Dd high, intermediate, and low NK cells
were 46   8%, 26   7%, and 17   6%, respectively, rela-
tive to Ly49A levels on H-2b NK cells. Thus, in Dd mosaic
mice, low Dd levels on NK cells are associated with low
Ly49A levels. In contrast, the lack of Dd in B6 mice is asso-
ciated with high Ly49A levels. MFIs of Ly49C/I, Ly49G2,
and Ly49D were not different between the three Dd-
defined types of NK cells (Fig. 2 and data not shown).
Among possible mechanisms that could account for these
findings, Ly49A  NK cells may be resistant to complete Dd
recombination, perhaps due to an inactivity of the Mx pro-
moter in these cells. To address this possibility we enforced
Dd recombination in vivo by inducing Cre expression. 10 d
after the last intraperitoneal injection with the IFN-inducer
polyI/C,  86% of Dd   MxCre splenocytes were Dd low
(data not shown). A comparable fraction (89%) of Dd low
cells was observed among NK cells that do not express
Ly49A (Fig. 3 a). In contrast, Ly49A  NK cells still con-
tained significant amounts of Dd, as only 54% of cells were
in the Dd low gate (Fig. 3 a). After the culture of nylon
wool nonadherent cells in IL-2 for 10 d however, essen-
tially all (98%) Ly49A  NK cells were Dd low (Fig. 3 b).
Thus, the complete loss of Dd expression among cultured
Ly49A  NK cells indicates that these cells too had recom-
bined their Dd Tg. However, the ex vivo analysis suggests
that Dd disappears slowly from Ly49A  NK cells when
compared with Ly49A  NK cells or lymphocytes.
H-2D Ligand Uptake by Ly49A  NK Cells In Vivo. If
recombination of the Dd Tg also occurs in Ly49A  NK
cells, Ly49A  cells that have lost the Tg may be able to
take up Dd from environmental Dd  cells. To address this
possibility we generated mixed bone marrow chimeras. Le-
thally irradiated H-2bDd recipients were reconstituted with
a mixture of bone marrow cells derived from B6 (H-2b)
and H-2bDd donors. To discriminate the two types of do-
nor cells, we used B6 mice expressing the CD45.1 isoform
of the panleucocyte marker CD45 while H-2bDd mice
were CD45.2 . This allowed us to discriminate donor cells
independently from Dd expression.
Hematopoietic chimerism in recipient mice was analyzed
2–4 mo after reconstitution through staining with anti-
CD45.1 and anti-CD45.2 mAbs.  33% of lymphocytes in
spleen (Fig. 4 a), blood and bone marrow (data not shown)
were CD45.1  and thus of B6 origin. When splenic NK
cells were discriminated through CD45 expression, a nor-
mal percentage (18–20%) of Ly49A  cells was identified
among CD45.1  (H-2b) and CD45.1  (H-2bDd) cells (Fig.
4 a). However, CD45.1  NK cells (of B6 origin) appeared
as Dd intermediate cells (Fig. 4 b). As these cells are geneti-
cally Dd-deficient, our findings imply that they have ac-
quired Dd molecules from environmental Dd  cells in vivo.
Similarly, Ly49A  NK cells that have recombined their Dd
Tg in the Dd   MxCre situation may thus take up Dd from
environmental Dd  cells and appear as Dd intermediate cells.
On the Dd-expressing NK cells, Ly49A expression levels
in the mixed chimeras were  50% of control B6 mice. In
contrast, on CD45.1  (H-2b) NK cells Ly49A levels were
approximately threefold further reduced (16% of B6 con-
trols). Thus, similar to mosaic mice, in a Dd  environment
in mixed H-2b/H-2bDd bone marrow chimeras the lack of
endogenous Dd on Ly49A  NK cells is associated with very
low Ly49A levels.
H-2D Ligand Uptake via the Ly49A Receptor In Vitro.
To obtain further evidence that Dd molecules can be ac-
quired by Ly49A  NK cells, we mixed splenocytes from
B6 (H-2b) mice with splenocytes from Dd Tg or from
B10.D2 (H-2d) mice. The cells were mixed and incubated
at 37 C for 2 h before staining and FACS® analysis. Indeed,
Ly49A  NK cells from B6 mice became significantly Dd 
(Fig. 5 a). The transfer of Dd molecules was completely
blocked by the addition of either the anti-Dd mAb 34–4-
20S (Fig. 5 a) or the anti-Ly49A mAb A1 (data not shown)
Figure 3. Enforced deletion of the Dd Tg in Dd   MxCre mice. Histo-
grams show Dd expression on NK cells from control PBS-injected Dd  
MxCre (left), polyI/C injected Dd   MxCre (middle), and polyI/C in-
jected Dd single Tg mice (right). Freshly isolated nylon-wool nonadher-
ent splenocytes (a) or cultures established thereof (10 d in IL-2 containing
medium) (b) were stained with mAbs to Ly49A, NK1.1, CD3, and Dd
and analyzed by four color flow cytometry. Ly49A  (top) and Ly49A 
(bottom) NK cells (NK1.1 CD3 ) were separately analyzed for Dd ex-
pression. Numbers in histograms indicate the percentages of NK cells
with low Dd expression.1535 Zimmer et al.
demonstrating that H-2Dd uptake is dependent on the
Ly49A receptor. In agreement with the in vivo data, the
majority of Ly49C/I , Ly49G2 , and Ly49D  NK cells
from B6 mice remained Dd low (data not shown).
H-2D Ligand Uptake Reflects the Affinity of Ly49A to Dif-
ferent H-2D Alleles. To determine the specificity of acqui-
sition of class I molecules by Ly49A, we analyzed two addi-
tional MHC class I molecules, Dk and Db. The former
represents a strong ligand of Ly49A, although with some-
what lower affinity than Dd. A very weak interaction of
Ly49A with Db is mainly suggested by developmental and
functional evidence (8–10, 23, 24). The “donors” of Dd,
Dk, and Db molecules (splenocytes from Dd single Tg or
B10.D2 [H-2d], B10.BR [H-2k], and B6 [H-2b] mice, re-
spectively) were mixed with MHC class I–deficient ( 2m / )
splenocytes, centrifuged, incubated, and stained as above.
Class I uptake was determined based on increases of Dd, Dk,
and Db MFI on  2m /  Ly49A  NK cells. Ly49A  NK
cells from  2m /  mice efficiently acquired Dd (28   9%
as compared with Dd levels on H-2d Ly49A  NK cells) and
less efficiently Dk (17   5% of Dk levels on H-2k Ly49A 
NK cells). In contrast, Db acquisition was insignificant (Fig.
5 b). The extent of uptake thus reflects the affinity of
Ly49A for certain H-2D alleles. A requirement for high af-
finity interactions may explain why Dd uptake via Ly49C/I,
Ly49G2, and Ly49D receptors was not detected.
H-2D Ligand Expression by Ly49A  NK Cells Prevents
Ligand Uptake. We further investigated whether Ly49A 
NK cells expressing themselves a ligand for Ly49A (Dd or
Dk), are able to acquire a ligand from environmental cells.
For this purpose, we mixed splenocytes from H-2d mice
with those from H-2k mice. Interestingly, the acquisition
of Dd by H-2k Ly49A  NK cells as well as the acquisition
of Dk by H-2d Ly49A  NK cells was very low to undetect-
able (Fig. 5 b). In contrast, Ly49A  NK cells from H-2b
mice efficiently took up Dd as well as Dk (Fig. 5 b).
To confirm the relative absence of H-2D ligand uptake
from environmental cells in the presence of a ligand on
Ly49A  NK cells, we crossed Dd     MxCre mice to
B10.BR (H-2k) mice. In control Dd   MxCre mice (H-2b/b
background), we observed significantly fewer Dd low
Ly49A  as compared with Ly49A  NK cells (Fig. 6), consis-
Figure 4. Uptake of Dd molecules by Ly49A  NK cells in vivo. Le-
thally irradiated H-2bDd (CD45.2 ) recipients were reconstituted with a
1:1 mixture of bone marrow cells from B6 (CD45.1 ) and H-2bDd
(CD45.2 ) mice and spleens analyzed 2–4 mo after reconstitution. The
data shown are representative of three different experiments with similar
results. (a) Nylon wool nonadherent splenocytes from a mixed bone mar-
row chimera were stained with mAbs to Ly49A, NK1.1, CD3, and
CD45.1 and analyzed by four color flow cytometry. Ly49A expression
was analyzed among CD45.1  (B6) and CD45.1  (H-2bDd) NK cells.
Numbers correspond to the percentages of Ly49A  NK cells and the ex-
pression levels of Ly49A (MFI). (b) Density plots show expression of
Ly49A versus Dd on splenic NK cells (NK1.1 CD3 ) (left), Ly49A versus
Dd on gated CD45.1  (H-2b-derived) NK1.1  splenocytes (middle), and
Ly49A versus Dd on gated CD45.2  (H-2bDd-derived) NK1.1  spleno-
cytes (right) from a representative mixed chimera.
Figure 5. Specificity of uptake of H-2D alleles in vitro. (a) Total spleno-
cytes from B6 (H-2b) and B10.D2 (H-2d) mice were mixed and incubated
for 2 h at 37 C. The expression of Ly49A versus Dd among gated NK cells
(NK1.1 CD3 ) is shown for B6 (top left) and B10.D2 cells (top right).
Mixed populations of B6 plus B10.D2 cells were left untreated (bottom
left) or incubated with an anti-Dd mAb (34–4-20S) (bottom right). (b) To-
tal splenocytes from MHC class I–deficient ( 2m / ), B6 (H-2b), Dd sin-
gle Tg (H-2bDd), B10.D2 (H-2d), or B10.BR (H-2k) mice were mixed in
various combinations and stained with mAbs to Dd, Dk, or Db together
with mAbs to Ly49A, CD3, and NK1.1. Expression of Ly49A versus Dd,
Dk, or Db was analyzed among Ly49A  NK cells (NK1.1 CD3 ). The
MFI of H-2D alleles on Ly49A  NK cells expressing the respective gene
was arbitrarily assigned the value 100 (R1 in a). The extent of uptake of
the H-2D alleles by Ly49A  NK cells was determined by the MFI in R2
and indicated as a percentage of R1. The MFI of the H-2D allele on
Ly49A  NK cells that do not express the respective gene and that were not
mixed with other cells represents the background staining. Data show
means (  SD) of usually three or more independent experiments.1536 Conditions for Ly49A-mediated H-2D Ligand Uptake
tent with Dd uptake via Ly49A. In contrast, in Dd   MxCre
mice of H-2k/b background, the fraction of Dd low cells was
similar among Ly49A  and Ly49A  NK cells (Fig. 6). These
findings suggest that Dd uptake by Ly49A did not occur.
They corroborate the in vitro results and suggest that H-2
ligand uptake from environmental cells does not detectably
occur when a H-2 ligand is expressed on Ly49A  NK cells.
Reduced Binding of mAb A1 to Ly49A on Dd  NK Cells.
The above findings raise the possibility that H-2 ligand ex-
pression by NK cells influences the structure of Ly49A
and/or its accessibility. To test this possibility we stained
NK cells from different haplotypes with the available anti-
Ly49A mAbs A1, JR9–318, and YE1–48. NK cells from
 2m /  mice stained brightly with all mAbs. Staining in-
tensities with each of the three mAbs were  20–30%
lower on H-2b NK cells (data not shown). On H-2d and
H-2bDd NK cells, the intensity of Ly49A staining with
JR9–318 and YE1–48 mAbs was between 40–50% of B6
controls, in agreement with numerous previous studies re-
viewed in reference 25. Even though considerable amounts
of Ly49A were still detected using the above mAbs, A1
staining of H-2d and H-2bDd NK cells was reduced to 14  
4% of B6 controls (Fig. 7 and data not shown). The bind-
ing of mAb A1 to its epitope on Ly49A is thus strongly and
selectively impaired as a consequence of Dd expression.
Reduced Inhibitory Capacity of Ly49A on NK Cells from
Dd  Mice. We have further tested whether the Dd-depen-
dent reduction of ligand uptake by and binding of A1 to
Ly49A correlated with an altered inhibitory function of
Ly49A  NK cells from Dd  mice. To circumvent mAb-
dependent purification steps we have used effector cell
populations from Ly49A Tg mice that express Ly49A on all
NK cells (20). Ly49A expressed by Dd  NK cells inhibited
the lysis of Dd  lymphoblast targets (13), consistent with
other reports (14–16, 26, 27). In contrast, H-2bDd tumor
targets (C1498 Dd) were efficiently lysed by NK cells from
Dd   Ly49A Tg (H-2bDd) mice. These targets were essen-
tially not killed by NK cells from H-2b Ly49A Tg mice,
even though all NK cell populations efficiently killed the
parental C1498 target cells (Fig. 8). Our data confirm and
extent earlier reports (14, 27), indicating that the inhibitory
capacity of Ly49A on H-2bDd NK cells is at least 10-fold
reduced as compared with H-2b NK cells. In H-2bDd NK
cells, Ly49A-mediated inhibition may be sufficient to pre-
vent the lysis of lymphoblast targets but not that of C1498
Dd cells which most likely provide more activation signals
to NK cells. These findings correlate well with reduced
H-2 ligand uptake, limited Ly49A downmodulation, and
reduced A1 binding and suggest that structural constraints
limit Ly49A binding to H-2 ligand when a H-2 ligand is
expressed on NK cells themselves.
Discussion
We have generated a novel mouse model in which cells
with high, intermediate, and low levels of a MHC class I
molecule coexist in individual mice. Surprisingly, NK cells
expressing Ly49A were virtually all Dd high or intermedi-
ate but not Dd low. Mixed bone marrow chimeras estab-
Figure 6. H-2k expression prevents Dd uptake in vivo. Splenocytes
from H-2b/b D d   MxCre and H-2b/k D d   MxCre double Tg mice
were stained with mAbs to Ly49A, NK1.1, CD3, and Dd and analyzed by
four color flow cytometry. (a) Histograms show Dd expression on
Ly49A  (top) and Ly49A  (bottom) NK cells (NK1.1 CD3 ) of the two
types of mice. Numbers in histograms indicate the percentages of NK
cells with low Dd expression. (b) Density plots show expression of Ly49A
versus Dd on gated NK cells (NK1.1 CD3 ) from the two types of mice.
Figure 7. Reduced binding of mAb A1 to Ly49A on Dd  NK cells.
Splenocytes from B6 (H-2b) and B10.D2 (H-2d) mice were stained with
mAbs to NK1.1 and CD3 together with the indicated anti-Ly49A mAbs
(JR9, YE1–48, or A1), and analyzed by flow cytometry. Histograms
show anti-Ly49A stainings using the indicated mAb among gated NK
cells (NK1.1 CD3 ). Numbers indicate percentages of gated Ly49A 
NK cells and the MFI of Ly49A expression. Numbers in brackets express
the MFI as a percentage of the one obtained for Ly49A  NK cells from
B6 mice ( 100).1537 Zimmer et al.
lished that H-2b Ly49A  NK cells can acquire Dd mole-
cules from environmental Dd  cells in vivo. The specific
acquisition of Dd molecules via the Ly49A receptor was
further demonstrated by in vitro coculture experiments. In-
deed, the Ly49A receptor mediated only the uptake of its
strong ligands Dd or Dk but not of the weak ligand Db.
The uptake of class I molecules by Ly49A  NK cells re-
sembles the acquisition of target cell molecules by other
lymphocyte populations. CD8  T lymphocytes rapidly ac-
quire specific peptide–MHC class I complexes from APC
(28–30). This acquisition is mediated through the TCR
and strictly depends on the presence of the appropriate
peptide/MHC class I complex. Furthermore, CD8  and
CD4  T cells acquire, specifically through the CD28 co-
stimulatory molecule, CD80 from APC (29, 31). Similarly,
B cells can take up specific membrane-bound antigens via
their BCR (32). Although mediated through specific
TCR–MHC, CD28–CD80, or BCR–antigen interactions,
the acquisition is often not limited to these particular
ligands but extends to various other cell surface molecules,
as entire membrane fragments may be transferred from
APC to T cells (30). In most of these situations, the result-
ing complexes are rapidly internalized and degraded (28,
29, 32). It seems thus likely that also in NK cells Ly49A–Dd
complexes are subject to internalization and degradation.
Unexpectedly, when NK cells expressed Dd, the Ly49A-
mediated acquisition of Dk, an alternative Ly49A ligand,
from environmental cells was very inefficient. H-2 ligand ex-
pression by Ly49A  NK cells thus interferes with ligand
uptake mediated by Ly49A. It is useful to consider these
findings in the context of the recent resolution of the crys-
tallographic structure of the Ly49A/H-2Dd complex (19).
This structure revealed the interaction of Ly49A with two
distinct sites of Dd. Ly49A interacted with amino terminal
residues of the  1 helix and COOH-terminal residues of
the  2 helix of Dd (site 1). The other site is located beneath
the floor of the peptide binding groove, making contact
with residues of the  2,  3, and  2m domains (site 2). The
relative importance of these two sites (as well as additional
residues identified by site directed mutagenesis) for the in-
teraction of Ly49A with Dd on target cells (interaction in
trans) has not been resolved (33–37). It is possible that in-
teractions at both sites are required for functional NK cell–
target cell interactions. As a surprise, however, in addition
to an interaction in trans, site 2 may allow an interaction of
Dd with Ly49A on the same cell (cis interaction; reference
19). Therefore, we propose that the uptake of Dd from en-
vironmental cells is severely impaired due to an interaction
of Ly49A in cis with its Dd ligand.
A number of findings reported here and by others are in
agreement with cis effects of Dd on Ly49A. Ly49A levels
on NK cells are downmodulated approximately twofold in
the presence as compared with the absence of Dd based on
antibody stainings (14, 38). Surprisingly, in a Dd  environ-
ment, Ly49A  NK cells which themselves do not express
Dd are more susceptible to Ly49A downmodulation than
those expressing Dd (Figs. 2 and 4; reference 39). Indeed,
Dk expression in cis limited Ly49A downmodulation upon
the interaction with Dd in trans (Fig. 6 b).
Historically, Ly49A  NK cells were initially not detect-
able in H-2d mice using mAb A1. Indeed, we find that the
staining with mAb A1 is at least fivefold less intense than on
H-2b NK cells. That is in contrast to two other mAbs,
which yielded twofold reductions. Binding of mAb A1 to
its epitope is thus specifically affected by Dd expression on
NK cells. The binding of mAb A1 to the carbohydrate rec-
ognition domain of Ly49A together with its binding to
Ly49AB6, Ly49ANOD, and Ly49PNOD but not to Ly49ABalb
suggests that the A1 epitope depends on a threonine resi-
due on position 138 of Ly49A (40–42). Interestingly, this
residue makes contact with site 2 of the Dd molecule (19).
A1 binding to Ly49A may thus be inefficient because Dd is
associated with Ly49A, thereby masking the A1 epitope.
Along those same lines it was reported that Dd tetramers
readily bind to Ly49A on H-2b NK cells. However, they
do apparently not bind well to Ly49A expressed on H-2d
NK cells (10, 43). This was explained in principal by the
(twofold) reduced levels of Ly49A on NK cells from H-2d
compared with those from H-2b mice (based on mAb
stainings) having a critical threshold effect obliterating tet-
ramer staining. However, soluble Ly49A reagents readily
interacted with Dd expressed on various lymphocyte popu-
lations (44–46). This apparent discrepancy is readily re-
solved if H-2 ligand expression by Ly49A receptor bearing
NK cells renders Ly49A interactions with Dd ligands en-
countered in trans inefficient. Therefore, collectively there
is ample evidence that Dd expression by Ly49A  NK cells
alters the accessibility of the Ly49A receptor. These find-
ings are all compatible with an association in cis of Dd with
Ly49A. We are currently attempting to obtain direct evi-
dence for such an association.
Is ligand loss from or ligand uptake by Ly49A  NK cells
of functional relevance? First, we have considered the possi-
Figure 8. Inefficient inhibition of Dd  NK cells by Ly49A. Short-term
(3 d) IL-2–activated NK cells were generated from Ly49A single Tg (H-2b)
(black squares), Dd single Tg (H-2bDd) (white circles), and Dd   Ly49A
double Tg (H-2bDd) (black triangles) mice. Cytotoxic activity of these
preparations to the tumor cell line C1498 (H-2b) and Dd-transfected
C1498 (C1498 Dd) was tested in a standard 4-h Cr release assay.1538 Conditions for Ly49A-mediated H-2D Ligand Uptake
bility that the loss of the Dd gene by Ly49A  NK cells,
which may terminate a cis interaction, is relevant for the
survival of these NK cells. Indeed, it has been shown that
the Cre/loxP–mediated loss of surface Igs (BCR) on mature
B cells leads to their rapid apoptotic death, suggesting that
the BCR provides survival signals to B cells (47). A similar
survival signal provided to NK cells through Ly49A–Dd in-
teractions in our model seems unlikely, since the fraction of
Ly49A  cells among total NK cells was not reduced in Dd  
MxCre mice. In addition, even the enforced deletion of Dd
using polyI/C treatment of Dd   MxCre mice, did not
negatively affect the number of Ly49A  NK cells. Although
it could be argued that in Dd   MxCre mice Ly49A  NK
cells are never completely devoid of Dd.
A role of H-2 ligand uptake in vivo is not immediately
obvious, especially since it seems to efficiently occur only
in exceptional cases such as a class I mosaic situation. It is
also worth to point out that in contrast to T cells, the func-
tional consequence of an interaction that results in ligand
uptake, is NK cell inhibition and not cellular activation.
One could thus envisage two roles for ligand uptake: first it
may facilitate the detachment from target cells and/or
ligand uptake could participate in inhibitory signaling per-
haps once the complex has been internalized (48). Indeed,
Ly49A-mediated ligand uptake correlates with efficient NK
cell inhibition in H-2b NK cells.
While the above issues remain to be addressed, the rela-
tive absence of ligand uptake by Ly49A has prompted us to
reevaluate the accessibility and function of Ly49A on Dd 
NK cells. Indeed, the inhibitory capacity of the Ly49A re-
ceptor on H-2bDd NK cells was considerably reduced as
compared with H-2b NK cells. Dd  tumor target cells that
inhibited lysis by Ly49A  NK cells from H-2b mice were
readily killed by Ly49A  NK cells from H-2bDd mice (Fig.
8; references 14 and 27). The latter NK cells are thus more
sensitive to increases in activation signals and/or subtle re-
ductions in Dd levels. Previously, this effect has been at-
tributed to the approximately twofold lower levels of
Ly49A on H-2d as compared with H-2b NK cells. How-
ever, our results suggest that the inhibitory capacity of
Ly49A on H-2d NK cells is at least 10-fold reduced as
compared with H-2b NK cells (Fig. 8). Based on these
findings it is conceivable that it is the limited accessibility
of Ly49A due to Dd expression in cis, which renders Dd 
Ly49A  NK cells particularly sensitive to detect subtle al-
terations in Dd expressing environmental cells. Hence, Dd
expression in cis may be important to establish the fine
specificity of Ly49A  NK cells.
Collectively, we provide evidence that H-2 ligand expres-
sion by NK cells significantly affects the behavior of the in-
hibitory Ly49A NK cell receptor. Ligand expression by NK
cells drastically reduces the accessibility of Ly49A to ligands
encountered in trans, on environmental cells. Reduced ac-
cessibility may be responsible for the increased sensitivity of
the Ly49A receptor in Dd  NK cells. Small reductions of Dd
levels and/or increases of ligands for activating receptors on
target cells are sufficient to abrogate Ly49A-mediated NK
cell inhibition, allowing target cell lysis to proceed.
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